Spotlight on Immuno-Oncology in Melanoma

Access Course


966d4d06-8467-4d53-97ef-f5df8727a722.jpgDrs. Weber, Luke, and Gangadhar discuss the latest updates to existing immunotherapies and examine where the future may lie. 

This activity is intended for hematologists, oncologists, dermatologists, and pathologists. 

The goal of this activity is to review the latest advances in immunotherapy for melanoma.



Approximate Time to Complete: 35 minutes


Course Available Beginning: Aug. 31, 2016


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png


Course Objectives
Upon completion of this activity, participants will be able to:
  • Examine emerging clinical trial data on the use of immune-oncologic agents in the management of melanoma
  • Evaluate the implications of recent clinical data on treatment strategies for patients with melanoma in the community oncology setting